As such, the outcome data from our Dutch cohort showed a trend toward a higher percentage of severe infections, whereas relapse rates seemed comparable to or even lower than international report studies investigating patients treated with CYC-based regimens.
← all excerpts
Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Netherlands.
1
—
—